Tidbits is a lighter take on the happenings in the CLL research community. Click below to catch up previous issues or to sign up to receive Tidbits.
Read CLL Research Momentum to stay informed about projects we are funding and progress made in the fight against CLL.
Good News for CLL Patients
CLL Global Alliance Meeting
Congratulations Dr. Wierda
CLL the New Era
We Are Not Done yet!
Celebrating Advances in CLL Research
Celebrating Advances in CLL Research
The Rocket has Launched
Curing CLL – The Big Push
CLL Global Alliance Meeting
Looking Back, Moving Forward
News from American Society of Hematology
Research Update • Giving Opportunities
Town Hall meeting on Octover 25, 2015 • Remembering Byron “Mack” Rankin, Jr.
CLL Global Alliance Meeting Highlights
Global Grantee Highlight – Dr. Elizabeth Shpall, MD and Dr. Katy Rezvani, MD, PhD • Save the Date for Town Hall meeting
Global Grantee Highlight – Dr. Deepah Sampath, PhD • New Targeted Combination Therapies • Town Meeting
Cancers Common in CLL Patients • Decade of Making a Difference
A True Hero: Mack Rankin • Protect Yourself Against the Flu • Landscape of CLL • New Projects • Start Using Cure with CLL?
Passion & Means • Q&A: Dr. Neil Kay • Green Tea Update • CLL Research Wish List • New Projects
MD Anderson Moon Shot • Summer Alliance Meeting • Expanding Collaborations • Targeted Treatments • Letter Writing Campaign • Grant Project Updates
Chronic versus acute • Immunotherapy • Q&A: Dr. Stephan Stilgenbauer • New projects • Partnership opportunities
Significance of historical information • Chimeric Antigen Receptors (CARs) • Q&A: Dr. Laurence Cooper • Bruton’s tyrosine kinase • Partner Perspective: Will Newman
Global collaborations • Alliance meeting • MicroRNAs • Q&A: Dr. George Calin • p53 • Stem cell transplant • Creative givingN
Philanthropy will cure CLL • Mouse models • Signal transduction inhibitors • CLL in the elderly • Patient symposium • Prognostic factors • Cord blood transplant
State of CLL research • CLL Global’s history • Alliance meeting • Alliance collaborations • Researchers in the background • Projects reach clinic
Genetics • Personalized therapy • Epstein-Barr virus • Clinical trial introduction • New projects
Targeting ROR1 • CLL pathways • Relapsed CLL • Stem cell transplant introduction • Beyond FCR • Genetics • Skin cancer • TCL1
Investing in CLL research • Genetics • FCR data • Microbead technology
How will CLL be cured? • Q&A: Dr. Emil J Freireich • Alliance update • 8-chloro-adenosine • New drugs • Secondary cancers • Flu shots • Ripple effect of grants
Alliance introduction • Targeting proteins • Cellular signals • Alliance meeting • Minimal residual disease • CLL immunity collaboration • Immune system education • Proactive patient
CLL microenvironment • Cure CLL now • Stat-3 • Single nucleotide polymorphisms • TCL1 • Alemtuzumab • Heavy water
Familial CLL • Prognostic factors • Educating T-cells • Mapping genes • Gene modification • ZAP-70 • CD38
Gene therapy studies • Initial grants • Green tea • Glycolycin • 8-chloro-adenosine • Protein expression • Indolent or aggressive CLL
